![Katie Dahlstrom](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Katie Dahlstrom
Direttore Tecnico/Scientifico/R&S presso THESEUS PHARMACEUTICALS, INC.
Posizioni attive di Katie Dahlstrom
Società | Posizione | Inizio | Fine |
---|---|---|---|
THESEUS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Katie Dahlstrom
Precedenti posizioni note di Katie Dahlstrom
Società | Posizione | Inizio | Fine |
---|---|---|---|
AGIOS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Katie Dahlstrom
Stonehill College, Inc. | Undergraduate Degree |
Boston University School of Medicine | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Theseus Pharmaceuticals, Inc.
![]() Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Katie Dahlstrom
- Esperienza